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Purpose: The purpose of this systematic review was to analyze and determine the 
effectiveness of Autologous Chondrocyte Implantation (ACI) when compared with other 
treatment modalities which includes microfracture, mosaicplasty, abrasionplasty, bone 
marrow derived mesenchymal stem cell (BMSC) and matrix assisted autologous 
chondrocyte implantation (MACI). 
Methods: Literature search using online databases PubMed, Scopus, National Institute 
for Clinical Excellence (NICE) and Cochrane Controlled Trial Register regarding all cell 
based therapies and other interventions for chondral lesions was explored. Data on 
clinical outcome and repair quality were analyzed. Duplicates and irrelevant articles 
were omitted. Result: Seventeen (n=17) studies were included in this review. Among the 
four trials on ACI versus mosaicplasty, 2 studies showed no differences in clinical 
scores, 1 suggested similar performance while the other suggested better results in 
tissue quality for ACI. A systematically performed assessment comparing ACI with 
microfracture shows better clinical outcomes and higher tissue quality after ACI. Studies 
comparing ACI with MACI or BMSC demonstrated similar results. Although many of 
these studies had substantial flaws, on the overall, the evidence comparing ACI with 
other treatment modalities shows better clinical outcomes and higher tissue quality. 
Conclusion: Despite significant differences between the methodologies employed by 
different researchers, we can conclude that all except 2 studies demonstrated ACI being 
the better treatment for cartilage defects. However final conclusions regarding long-term 
effects are still difficult and therefore future studies are needed to answer the long term 
effects of ACI.  
 
